RecruitingNCT06404645

A Clinical Prospective Observational Study of Near Infrared Spectroscopy to Detect Subcranial Hematoma


Sponsor

RenJi Hospital

Enrollment

20 participants

Start Date

May 1, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This trial is a clinical prospective observational study. Cases meeting the entry criteria undergo near-infrared spectroscopy(NIRS)detection. Data collection mainly includes hematoma thickness on cranial CT, and bilateral NIRS data.This trial tries to explore the reliability and accuracy of NIRS detection of subcranial hematoma.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Age above 18 years old
  • Unilateral subcranial hemorrhage confirmed by cranial CT

Exclusion Criteria3

  • Bilateral subcranial hemorrhage
  • Intracranial pneumoperitoneum in the location of the hemorrhage on cranial CT
  • Obvious skull fracture in the location of hemorrhage on cranial CT

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENear-infrared spectroscopy detection

Cranial CT confirm intracranial haematoma. Then the near-infrared spectroscopy device to collect date by red sensor probe in the corresponding position on the scalp and blue sensor probe on the opposite side of the hematoma. Collect data for 10 minutes.


Locations(1)

Brain Injury Center, Renji Hospital, School of Medicine, Shanghai Jiao Tong University

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06404645


Related Trials